{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:52:38Z","timestamp":1773337958557,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.mce.2011.12.015","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T23:19:46Z","timestamp":1326151186000},"page":"249-263","source":"Crossref","is-referenced-by-count":41,"title":["The CXCL12\/CXCR4 axis promotes ligand-independent activation of the androgen receptor"],"prefix":"10.1016","volume":"351","author":[{"given":"Sathish","family":"Kasina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill A.","family":"Macoska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.12.015_b0005","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/MCB.19.9.6085","article-title":"The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription","volume":"19","author":"Alen","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0010","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jsbmb.2008.06.008","article-title":"Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells","volume":"111","author":"Arnold","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mce.2004.04.013","article-title":"Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells","volume":"222","author":"Attardi","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1474-9726.2005.00173.x","article-title":"CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro","volume":"4","author":"Begley","year":"2005","journal-title":"Aging Cell."},{"key":"10.1016\/j.mce.2011.12.015_b0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cyto.2008.05.012","article-title":"The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy","volume":"43","author":"Begley","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.mce.2011.12.015_b0035","doi-asserted-by":"crossref","first-page":"26767","DOI":"10.1074\/jbc.M700440200","article-title":"CXCL12 activates a robust transcriptional response in human prostate epithelial cells","volume":"282","author":"Begley","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.12.015_b0040","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/mend.12.8.0153","article-title":"Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)","volume":"12","author":"Berrevoets","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0045","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/MCB.19.12.8383","article-title":"The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1","volume":"19","author":"Bevan","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mce.2011.12.015_b0055","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mce.2011.12.015_b0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcb.240510203","article-title":"Multiple mechanisms for regulation of steroid hormone action","volume":"51","author":"Burnstein","year":"1993","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2011.12.015_b0065","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM197606102942405","article-title":"Mechanism of action of the sex steroid hormones (first of three parts)","volume":"294","author":"Chan","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.12.015_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"Chen","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2011.12.015_b0075","first-page":"5030","article-title":"Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process","volume":"59","author":"Craft","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0080","first-page":"1095","article-title":"The AR in hormone-refractory prostate cancer: relevance of different mechanisms of AR signaling (Review)","volume":"23","author":"Cronauer","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mce.2011.12.015_b0085","first-page":"5474","article-title":"AR activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor","volume":"54","author":"Culig","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I","article-title":"Expression, structure, and function of AR in advanced prostatic carcinoma","volume":"35","author":"Culig","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcb.20477","article-title":"Interleukin-6 regulation of prostate cancer cell growth","volume":"95","author":"Culig","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"216","key":"10.1016\/j.mce.2011.12.015_b0100","first-page":"re2","article-title":"G proteins in cancer: the prostate cancer paradigm","author":"Daaka","year":"2004","journal-title":"Sci. STKE"},{"key":"10.1016\/j.mce.2011.12.015_b0105","first-page":"2399","article-title":"Synergistic activation of the AR by bombesin and low-dose androgen","volume":"8","author":"Dai","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.mce.2011.12.015_b0110","doi-asserted-by":"crossref","first-page":"e11475","DOI":"10.1371\/journal.pone.0011475","article-title":"Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling","volume":"5","author":"D\u2019Antonio","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2011.12.015_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00413-5","article-title":"The role of androgens and the AR in prostate cancer","volume":"187","author":"Debes","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2011.12.015_b0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pros.10199","article-title":"Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models","volume":"54","author":"Denmeade","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/mend.12.2.0065","article-title":"Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities","volume":"12","author":"Ding","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0198-072","article-title":"AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor","volume":"4","author":"Donzella","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2011.12.015_b0135","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1464-410X.2005.05527.x","article-title":"The androgen receptor and signal-transduction pathways in hormone refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways","volume":"95","author":"Edwards","year":"2005","journal-title":"B.J.U. Int."},{"key":"10.1016\/j.mce.2011.12.015_b0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0960-0760(97)00054-X","article-title":"LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids","volume":"62","author":"Esquenet","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.2990210205","article-title":"Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretions","volume":"21","author":"Fong","year":"1992","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1210\/me.2009-0010","article-title":"Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro","volume":"23","author":"Frigo","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0155","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1677\/joe.0.113R007","article-title":"ICI 176, 334: a novel non-steroidal, peripherally selective antiandrogen","volume":"113","author":"Furr","year":"1987","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0160","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jcem.80.4.7714070","article-title":"Prolonging survival in metastatic prostate cancer: the case for adrenal androgens \u2013 overview and summary of therapeutic controversies in prostatic cancer","volume":"80","author":"Geller","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.12.015_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1677\/erc.1.00835","article-title":"Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation","volume":"12","author":"Ghosh","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2011.12.015_b0170","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1074\/jbc.M307649200","article-title":"Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer","volume":"279","author":"Gregory","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.12.015_b0175","first-page":"4315","article-title":"A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy","volume":"61","author":"Gregory","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0180","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1093\/nar\/16.12.5263","article-title":"Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus","volume":"16","author":"Ham","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mce.2011.12.015_b0185","first-page":"4640","article-title":"Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the AR","volume":"58","author":"Hobisch","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0190","first-page":"115","article-title":"The LNCaP cell line \u2013 a new model for studies on human prostatic carcinoma","volume":"37","author":"Horoszewicz","year":"1980","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.mce.2011.12.015_b0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mce.2011.12.015_b0200","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1128\/MCB.00581-06","article-title":"Locus-wide chromatin remodeling and enhanced AR-mediated transcription in recurrent prostate tumor cells","volume":"26","author":"Jia","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1541-7786.MCR-08-0400","article-title":"Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP","volume":"7","author":"Karpf","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2184.2009.00645.x","article-title":"ADAM-mediated amphiregulin shedding and EGFR transactivation","volume":"42","author":"Kasina","year":"2009","journal-title":"Cell. Prolif."},{"key":"10.1016\/j.mce.2011.12.015_b0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm0497-402","article-title":"Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice","volume":"3","author":"Klein","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2011.12.015_b0220","first-page":"163","article-title":"VCaP, a cell-based model system of human prostate cancer","volume":"15","author":"Korenchuk","year":"2001","journal-title":"In Vivo"},{"key":"10.1016\/j.mce.2011.12.015_b0225","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1158\/0008-5472.CAN-04-0272","article-title":"Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer","volume":"64","author":"Kreisberg","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-230X(10)07005-3","article-title":"Androgen regulation of gene expression","volume":"107","author":"Lamont","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0235","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1128\/MCB.21.24.8385-8397.2001","article-title":"Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk\/Bmx, Src, and focal adhesion kinase","volume":"21","author":"Lee","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0240","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.onc.1207344","article-title":"Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2011.12.015_b0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pros.20865","article-title":"Interleukin-4 activates AR through CBP\/p300","volume":"69","author":"Lee","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0250","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1206735","article-title":"Interleukin-4 enhances prostate-specific antigen expression by activation of the AR and Akt pathway","volume":"22","author":"Lee","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2011.12.015_b0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pros.20218","article-title":"Requirement for NF-(kappa)B in interleukin-4-induced AR activation in prostate cancer cells","volume":"64","author":"Lee","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/pros.20691","article-title":"Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells","volume":"68","author":"Lee","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0265","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0270","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.121173298","article-title":"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor","volume":"98","author":"Lin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2011.12.015_b0275","first-page":"3550","article-title":"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer","volume":"61","author":"Linja","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0280","doi-asserted-by":"crossref","first-page":"22177","DOI":"10.1074\/jbc.M010718200","article-title":"Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity","volume":"276","author":"Lopez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.12.015_b0285","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10585-005-0056-6","article-title":"Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor","volume":"21","author":"Lu","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.mce.2011.12.015_b0290","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/MCB.19.9.6164","article-title":"Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins","volume":"19","author":"Ma","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0295","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1541-7786.MCR-07-0032","article-title":"Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells","volume":"5","author":"MacManus","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0300","first-page":"1168","article-title":"Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer","volume":"8","author":"Malik","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/ERC-08-0174","article-title":"Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the AR","volume":"16","author":"Malinowska","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2011.12.015_b0310","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/sj.bjc.6604152","article-title":"Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients","volume":"98","author":"McCall","year":"2008","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.mce.2011.12.015_b0315","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-10-1343","article-title":"Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer","volume":"71","author":"Mohler","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-0-387-69080-3_21","article-title":"Castration-recurrent prostate cancer is not androgen-independent","volume":"617","author":"Mohler","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0325","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily","volume":"270","author":"O\u00f1ate","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mce.2011.12.015_b0330","first-page":"105","article-title":"Phosphorylation of steroid hormone receptors","volume":"13","author":"Ort\u00ed","year":"1992","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2011.12.015_b0335","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1158\/1078-0432.CCR-06-0067","article-title":"Mechanisms underlying the development of androgen-independent prostate cancer","volume":"12","author":"Pienta","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0345","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1210\/mend-5-12-1921","article-title":"The promoter of the prostate-specific antigen gene contains a functional androgen responsive element","volume":"5","author":"Riegman","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0350","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1146\/annurev.immunol.22.012703.104543","article-title":"Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells","volume":"22","author":"Rot","year":"2004","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.mce.2011.12.015_b0355","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1128\/MCB.20.23.8720-8730.2000","article-title":"8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein","volume":"20","author":"Rowan","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2011.12.015_b0360","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1074\/jbc.275.6.4475","article-title":"Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway","volume":"275","author":"Rowan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.12.015_b0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1677\/erc.1.00525","article-title":"Targeting the AR: improving outcomes for castration-resistant prostate cancer","volume":"11","author":"Scher","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2011.12.015_b0370","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/carcin\/bgn109","article-title":"Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of AR expression and activation","volume":"29","author":"Seaton","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2011.12.015_b0375","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0022-5347(05)65822-3","article-title":"Her-2\/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease","volume":"166","author":"Shi","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.mce.2011.12.015_b0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11626-999-0115-4","article-title":"A new human prostate carcinoma cell line, 22Rv1","volume":"35","author":"Sramkoski","year":"1999","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.mce.2011.12.015_b0385","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ijc.10495","article-title":"Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer","volume":"100","author":"Steketee","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2011.12.015_b0390","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2010.05.015","article-title":"Trilostane, an inhibitor of 3\u03b2-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells","volume":"297","author":"Takizawa","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2011.12.015_b0395","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/mend.11.4.9906","article-title":"Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells","volume":"11","author":"Tan","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.12.015_b0400","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jcb.10653","article-title":"AR: a key molecule in the progression of prostate cancer to hormone independence","volume":"91","author":"Taplin","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2011.12.015_b0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002400050141","article-title":"Systemic treatment with epidermal growth factor but not insulin-like growth factor I decreases the involution of the prostate in castrated rats","volume":"28","author":"T\u00f8rring","year":"2000","journal-title":"Urol. Res."},{"key":"10.1016\/j.mce.2011.12.015_b0410","doi-asserted-by":"crossref","first-page":"38087","DOI":"10.1074\/jbc.M203313200","article-title":"Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells","volume":"277","author":"Ueda","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.12.015_b0415","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pros.10290","article-title":"Molecular characterization of human prostate carcinoma cell lines","volume":"57","author":"van Bokhoven","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2011.12.015_b0420","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2011.12.015_b0425","first-page":"6841","article-title":"HER-2\/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway","volume":"60","author":"Wen","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.12.015_b0430","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1073\/pnas.96.10.5458","article-title":"From HER2\/Neu signal cascade to AR and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells","volume":"96","author":"Yeh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711007428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711007428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T06:30:14Z","timestamp":1543300214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711007428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0303720711007428"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.12.015","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}